Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'PHARMACOKINETIC PARAMETERS' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 107 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Hing, JP; Woolfrey, SG; Greenslade, D; Wright, PMC
      Is mixed effects modeling or naive pooled data analysis preferred for the interpretation of single sample per subject toxicokinetic data?

      JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS
    2. Quinones-Torrelo, C; Sagrado, S; Villanueva-Camanas, RM; Medina-Hernandez, MJ
      Retention pharmacokinetic and pharmacodynamic parameter relationships of antihistamine drugs using biopartitioning micellar chromatography

      JOURNAL OF CHROMATOGRAPHY B
    3. Vallarino-Kelly, T; Morales-Ramirez, P
      Kinetics of micronucleus induction and cytotoxic activity of colchicine inmurine erythroblast in vivo

      MUTATION RESEARCH-GENETIC TOXICOLOGY AND ENVIRONMENTAL MUTAGENESIS
    4. Amisaki, T
      Gaussian quadrature as a numerical integration method for estimating area under the curve

      BIOLOGICAL & PHARMACEUTICAL BULLETIN
    5. Karalis, V; Claret, L; Iliadis, A; Macheras, P
      Fractal volume of drug distribution: It scales proportionally to body mass

      PHARMACEUTICAL RESEARCH
    6. Zuegge, J; Schneider, G; Coassolo, P; Lave, T
      Prediction of hepatic metabolic clearance - Comparison and assessment of prediction models

      CLINICAL PHARMACOKINETICS
    7. Mitchell, PB
      Therapeutic drug monitoring of psychotropic medications

      BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
    8. Vicini, P; Cobelli, C
      The iterative two-stage population approach to IVGTT minimal modeling: improved precision with reduced sampling

      AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
    9. Holz, M; Fahr, A
      Compartment modeling

      ADVANCED DRUG DELIVERY REVIEWS
    10. Erlendsdottir, H; Knudsen, JD; Odenholt, I; Cars, O; Espersen, F; Frimodt-Moller, N; Fuursted, K; Kristinsson, KG; Gudmundsson, S
      Penicillin pharmacodynamics in four experimental pneumococcal infection models

      ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
    11. Fernandez-Botran, R
      Soluble cytokine receptors: novel immunotherapeutic agents

      EXPERT OPINION ON INVESTIGATIONAL DRUGS
    12. Wu, G
      Sensitivity analysis of pharmacokinetic parameters in one-compartment models

      PHARMACOLOGICAL RESEARCH
    13. Knudsen, JD
      The importance of pharmacodynamic properties in treatment of penicillin resistant Streptococcus pneumoniae

      DANISH MEDICAL BULLETIN
    14. Sheiner, LB; Steimer, JL
      Pharmacokinetic/pharmacodynamic modeling in drug development

      ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY
    15. Holford, NHG; Kimko, HC; Monteleone, JPR; Peck, CC
      Simulation of clinical trials

      ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY
    16. Sivilotti, MLA; Burns, MJ; McMartin, KE; Brent, J
      Toxicokinetics of ethylene glycol during fomepizole therapy: Implications for management

      ANNALS OF EMERGENCY MEDICINE
    17. Valodia, PN; Seymour, MA; McFadyen, ML; Miller, R; Folb, PI
      Validation of population pharmacokinetic parameters of phenytoin using theparallel Michaelis-Menten and first-order elimination model

      THERAPEUTIC DRUG MONITORING
    18. Al-Said, MS; Al-Khamis, KI; Niazy, EM; El-Sayed, YM; Al-Rashood, KA; Al-Bella, S; Al-Yamani, MA; Al-Najjar, TA; Alam, SM; Dham, R; Qumaruzaman, QZ
      Bioequivalence evaluation of two brands of cefuroxime 500 mg tablets (Cefuzime((R)) and Zinnat((R))) in healthy human volunteers

      BIOPHARMACEUTICS & DRUG DISPOSITION
    19. Mahmood, I
      Critique of prospective allometric scaling: Does the emperor have clothes?(vol 40, pg 335, 2000)

      JOURNAL OF CLINICAL PHARMACOLOGY
    20. Bonate, PL; Howard, D
      Prospective allometric scaling. Does the emperor have clothes? (vol 40, pg335, 2000)

      JOURNAL OF CLINICAL PHARMACOLOGY
    21. Bonate, PL; Howard, D
      Critique of prospective allometric scaling: Does the emperor have clothes?

      JOURNAL OF CLINICAL PHARMACOLOGY
    22. Mahmood, I
      Prospective allometric scaling: Does the emperor have clothes?

      JOURNAL OF CLINICAL PHARMACOLOGY
    23. Mahmood, I
      Interspecies scaling: Role of protein binding in the prediction of clearance from animals to humans

      JOURNAL OF CLINICAL PHARMACOLOGY
    24. Poschel, KA; Bucha, E; Esslinger, HU; Nortersheuser, P; Jansa, U; Schindler, S; Nowak, G; Stein, G
      Pharmacodynamics and pharmacokinetics of polyethylene glycol-hirudin in patients with chronic renal failure

      KIDNEY INTERNATIONAL
    25. Bjorkman, S; Redke, F
      Clearance of fentanyl, alfentanil, methohexitone, thiopentone and ketaminein relation to estimated hepatic blood flow in several animal species: Application to prediction of clearance in man

      JOURNAL OF PHARMACY AND PHARMACOLOGY
    26. Wang, W
      A model to determine the optimal critical level and the monitoring intervals in condition-based maintenance

      INTERNATIONAL JOURNAL OF PRODUCTION RESEARCH
    27. Vermes, A; van der Sijs, H; Guchelaar, HJ
      Flucytosine: Correlation between toxicity and pharmacokinetic parameters

      CHEMOTHERAPY
    28. Morales-Ramirez, P; Vallarino-Kelly, T
      Relationship between the kinetics of micronuclei induction and the mechanism of chromosome break formation by methylnitrosourea in mice in vivo

      MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS
    29. Qato, MK; Mohammed, FA
      An improved HPLC assay for determination of nifedipine in human plasma after oral administration of Adalat

      STP PHARMA SCIENCES
    30. Lave, T; Coassolo, P; Reigner, B
      Prediction of hepatic metabolic clearance based on interspecies allometricscaling techniques and in vitro in vivo correlations

      CLINICAL PHARMACOKINETICS
    31. Valodia, P; Seymour, MA; Miller, R; McFadyen, ML; Folb, PI
      Factors influencing the population pharmacokinetic parameters of phenytoinin adult epileptic patients in South Africa

      THERAPEUTIC DRUG MONITORING
    32. Al-Rashood, KA; Al-Khamis, KI; El-Sayed, YM; Al-Bella, S; Al-Yamani, MA; Alam, SM; Dham, R
      Bioequivalence evaluation of lomefloxacin 400 mg tablets (Lomax((R)) versus Maxaquin((R))) in healthy human volunteers

      BIOPHARMACEUTICS & DRUG DISPOSITION
    33. Iavarone, L; Hoke, JF; Bottacini, M; Barnaby, R; Preston, GC
      First time in human for GV196771: Interspecies scaling applied on dose selection

      JOURNAL OF CLINICAL PHARMACOLOGY
    34. Woodnutt, G; Berry, V
      Two pharmacodynamic models for assessing the efficacy of amoxicillin-clavulanate against experimental respiratory tract infections caused by strains of Streptococcus pneumoniae

      ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
    35. Bright, GM; Julius, JR; Lima, J; Blethen, SL
      Growth hormone stimulation test results as predictors of recombinant humangrowth hormone treatment outcomes: Preliminary analysis of the National Cooperative Growth Study database

      PEDIATRICS
    36. Mahmood, I
      Allometric issues in drug development

      JOURNAL OF PHARMACEUTICAL SCIENCES
    37. Krecic-Shepard, IE; Barnas, CR; Slimko, J; Gorski, JC; Wainer, IW; Schwartz, JB
      In vivo comparison of putative probes of CYP3A4/5 activity: Erythromycin, dextromethorphan, and verapamil

      CLINICAL PHARMACOLOGY & THERAPEUTICS
    38. Lokiec, F
      Usefulness of a pharmacokinetic approach for clinical antineoplastic chemotherapy evaluation

      BULLETIN DU CANCER
    39. TURNIDGE JD
      THE PHARMACODYNAMICS OF BETA-LACTAMS

      Clinical infectious diseases
    40. PATRONBIZET F; MENTRE F; GENTON M; THOMASHAIMEZ C; MACCARIO J
      ASSESSMENT OF THE GLOBAL 2-STAGE METHOD TO EC50 DETERMINATION

      Journal of pharmacological and toxicological methods
    41. Rodrigues, AD
      Rational high-throughput screening in Preclinical Drug Metabolism

      MEDICINAL CHEMISTRY RESEARCH
    42. MARZO A; MONTI NC
      ACCEPTABLE AND UNACCEPTABLE PROCEDURES IN BIOAVAILABILITY AND BIOEQUIVALENCE TRIALS

      Pharmacological research
    43. ZELLNER D; FRANKEWITSCH T; KELLER F
      SYNTHESIS OF PHARMACOKINETIC PARAMETERS OF VANCOMYCIN VIA BOOTSTRAP METHODS

      International journal of clinical pharmacology and therapeutics
    44. NAJJAR TA; ABOUAUDA HS; GHILZAI NM
      INFLUENCE OF PIPERACILLIN ON THE PHARMACOKINETICS OF METHOTREXATE AND7-HYDROXYMETHOTREXATE

      Cancer chemotherapy and pharmacology
    45. KNUDSEN JD; FRIMODTMOLLER N; ESPERSEN F
      PHARMACODYNAMICS OF PENICILLIN ARE UNAFFECTED BY BACTERIAL-GROWTH PHASES OF STREPTOCOCCUS-PNEUMONIAE IN THE MOUSE PERITONITIS MODEL

      Journal of antimicrobial chemotherapy
    46. OTSUKA M; NAKAHIGASHI Y; MATSUDA Y; FOX JL; HIGUCHI WI; SUGIYAMA Y
      EFFECT OF GEOMETRICAL CEMENT SIZE ON IN-VITRO AND IN-VIVO INDOMETHACIN RELEASE FROM SELF-SETTING APATITE CEMENT

      Journal of controlled release
    47. ANDES D; CRAIG WA
      IN-VIVO ACTIVITIES OF AMOXICILLIN AND AMOXICILLIN-CLAVULANATE AGAINSTSTREPTOCOCCUS-PNEUMONIAE - APPLICATION TO BREAKPOINT DETERMINATIONS

      Antimicrobial agents and chemotherapy
    48. LEE KL; LEE KT; CHUNG HM; LIN YP
      ESTIMATION OF MEAN RELATIVE BIOAVAILABILITY OF CYCLOSPORINE SANDIMMUNE AND NEORAL USING NONMEM IN RENAL-TRANSPLANT RECIPIENTS

      Transplantation proceedings
    49. DALY JM; WILENS T
      THE USE OF TRICYCLIC ANTIDEPRESSANTS IN CHILDREN AND ADOLESCENTS

      The Pediatric clinics of North America
    50. MCCLURE JT; ROSIN E
      COMPARISON OF AMIKACIN DOSING REGIMENS IN NEUTROPENIC GUINEA-PIGS WITH ESCHERICHIA-COLI INFECTION

      American journal of veterinary research
    51. RESCIGNO A
      CLEARANCE, TURNOVER TIME, AND VOLUME OF DISTRIBUTION

      Pharmacological research
    52. RODRIGUES AD
      PRECLINICAL DRUG-METABOLISM IN THE AGE OF HIGH-THROUGHPUT SCREENING -AN INDUSTRIAL PERSPECTIVE

      Pharmaceutical research
    53. BEDOS JP; MOINE P
      EXPERIMENTAL-MODEL OF STREPTOCOCCUS-PNEUM ONIAE INFECTIONS WITH DIMINISHED SENSITIVITY OF PENICILLIN-G - ANALYSIS OF AMOXICILLIN ACTIVITY

      Medecine et maladies infectieuses
    54. OTSUKA M; NAKAHIGASHI Y; MATSUDA Y; FOX JL; HIGUCHI WI; SUGIYAMA Y
      A NOVEL SKELETAL DRUG-DELIVERY SYSTEM USING SELF-SETTING CALCIUM-PHOSPHATE CEMENT-VIII - THE RELATIONSHIP BETWEEN IN-VITRO AND IN-VIVO DRUG-RELEASE FROM INDOMETHACIN-CONTAINING CEMENT

      Journal of controlled release
    55. LUGO G; CASTANEDAHERNANDEZ G
      AMIKACIN BAYESIAN FORECASTING IN CRITICALLY ILL PATIENTS WITH SEPSIS AND CIRRHOSIS

      Therapeutic drug monitoring
    56. HARRISON LI; RIEDEL DJ; CHANG SF; JACOBSON JP; SELLERS JA; KANNIAINEN CM; CROWLEY JK; HINDERLING PH
      COMPARATIVE SERUM ESTRADIOL PROFILES FROM A NEW ONCE-A-WEEK TRANSDERMAL ESTRADIOL PATCH AND A TWICE-A-WEEK TRANSDERMAL ESTRADIOL PATCH

      Therapeutic drug monitoring
    57. TOD M; ALET P; LORTHOLARY O; PETITJEAN O
      IMPLEMENTATION AND EVALUATION OF A STOCHASTIC-CONTROL STRATEGY FOR INDIVIDUALIZING TEICOPLANIN DOSAGE REGIMEN

      Journal of pharmacokinetics and biopharmaceutics
    58. MOINE P; MAZOIT JX; BEDOS JP; VALLEE I; AZOULAYDUPUIS E
      CORRELATION BETWEEN IN-VITRO AND IN-VIVO ACTIVITY OF AMOXICILLIN AGAINST STREPTOCOCCUS-PNEUMONIAE IN A MURINE PNEUMONIA MODEL

      The Journal of pharmacology and experimental therapeutics
    59. HEATLEY JJ; BOOTHE DM; JENSEN JM
      DISPOSITION OF AMIKACIN IN FALLOW DEER (DAMA-DAMA) FOLLOWING A SINGLEINTRAMUSCULAR DOSE

      Journal of zoo and wildlife medicine
    60. FIRST MR; SCHROEDER TJ; MONACO AP; SIMPSON MA; CURTIS JJ; ARMENTI VT
      CYCLOSPORINE BIOAVAILABILITY - DOSING IMPLICATIONS AND IMPACT ON CLINICAL OUTCOMES IN SELECT TRANSPLANTATION SUBPOPULATIONS

      Clinical transplantation
    61. PRADHAN S; WU AT; LESKO LJ; CHEN ML; WILLIAMS RL
      BIOAVAILABILITY MEASUREMENTS OF METHAZOLAMIDE IN PLASMA, RED-BLOOD-CELLS AND WHOLE-BLOOD - IMPLICATIONS FOR BIOEQUIVALENCE STUDIES

      International journal of pharmaceutics
    62. GAMELIN E; BOISDRONCELLE M
      INDIVIDUAL DOSE ADJUSTMENT IN CANCER-CHEM OTHERAPY

      La Revue de medecine interne
    63. DEGAETANO A; MINGRONE G; CASTAGNETO M
      NONMEM IMPROVES GROUP PARAMETER-ESTIMATION FOR THE MINIMAL MODEL OF GLUCOSE KINETICS

      American journal of physiology: endocrinology and metabolism
    64. ANDRASSY K; ESCHENFELDER V
      ARE THE PHARMACOKINETIC PARAMETERS OF LOW-MOLECULAR-WEIGHT HEPARINS PREDICTIVE OF THEIR CLINICAL EFFICACY

      Thrombosis research
    65. SCHROEDER TJ; SHAH M; HARIHARAN S; FIRST MR
      INCREASED RESOURCES ARE REQUIRED IN PATIENTS WITH LOW CYCLOSPORINE BIOAVAILABILITY

      Transplantation proceedings
    66. BARONE G; BUNKE CM; CHOC MG; HRICIK DE; JIN JHJ; KLEIN JB; MARSH CL; MIN DI; PESCOVITZ MD; POLLAK R; PRUETT TL; STINSON JB; THOMPSON JS; VASQUEZ E; WAID T; WOMBOLT DG; WONG RL
      SAFETY AND TOLERABILITY OF NEORAL VS SANDIMMUNE - 1-YEAR DATA IN PRIMARY RENAL-ALLOGRAFT RECIPIENTS

      Transplantation proceedings
    67. KAHAN BD; WELSH M; SCHOENBERG L; RUTZKY LP; KATZ SM; URBAUER DL; VANBUREN CT
      VARIABLE ORAL ABSORPTION OF CYCLOSPORINE - A BIOPHARMACEUTICAL RISK FACTOR FOR CHRONIC RENAL, ALLOGRAFT-REJECTION

      Transplantation
    68. KEOWN P; LANDSBERG D; HALLORAN P; SHOKER A; RUSH D; JEFFERY J; RUSSELL D; STILLER C; MUIRHEAD N; COLE E; PAUL L; ZALTZMAN J; LOERTSCHER R; DALOZE P; DANDAVINO R; BOUCHER A; HANDA P; LAWEN J; BELITSKY P; PARFREY P
      A RANDOMIZED, PROSPECTIVE MULTICENTER PHARMACOEPIDEMIOLOGIC STUDY OF CYCLOSPORINE MICROEMULSION IN STABLE RENAL GRAFT RECIPIENTS

      Transplantation
    69. BRESSOLLE F; BOLOGNA C; EDNO L; BERNARD JC; GOMENI R; SANY J; COMBE B
      A LIMITED SAMPLING METHOD TO ESTIMATE METHOTREXATE PHARMACOKINETICS IN PATIENTS WITH RHEUMATOID-ARTHRITIS USING A BAYESIAN-APPROACH AND THEPOPULATION-DATA MODELING PROGRAM P-PHARM

      European Journal of Clinical Pharmacology
    70. ARVELO F; POUPON MF; BICHAT F; GROSSIN F; BOURGEOIS Y; JACROT M; BASTIAN G; LECHEVALIER T
      ADDING A REVERSER (VERAPAMIL) TO COMBINED CHEMOTHERAPY OVERRIDES RESISTANCE IN SMALL-CELL LUNG-CANCER XENOGRAFTS

      European journal of cancer
    71. TURNIDGE JD
      PHARMACODYNAMIC (KINETIC) CONSIDERATIONS IN THE TREATMENT OF MODERATELY SEVERE INFECTIONS WITH CEFOTAXIME

      Diagnostic microbiology and infectious disease
    72. ELSAYED YM; TABBARA KF; GOUDA MW
      EFFECT OF ACETAZOLAMIDE ON THE PHARMACOKINETICS OF CYCLOSPORINE IN RABBITS

      International journal of pharmaceutics
    73. GIRARD P; LAPORTESIMITSIDIS S; MISMETTI P; DECOUSUS H; BOISSEL JP
      INFLUENCE OF CONFOUNDING FACTORS ON DESIGNS FOR DOSE-EFFECT RELATIONSHIP ESTIMATES

      Statistics in medicine
    74. SULLIVAN MC; NIGHTINGALE CH; QUINTILIANI R; SWEENEY KR
      COMPARISON OF THE PHARMACODYNAMIC ACTIVITY OF CEFOTAXIME PLUS METRONIDAZOLE WITH CEFOXITIN AND AMPICILLIN PLUS SULBACTAM

      Pharmacotherapy
    75. PRESTON SL; BRICELAND LL
      SINGLE DAILY DOSING OF AMINOGLYCOSIDES

      Pharmacotherapy
    76. NAKASHIMA E; MATSUSHITA R; KIDO H; NAKAMURA M; ASAHI M; ICHIMURA F
      SYSTEMATIC-APPROACH TO A DOSAGE REGIMEN FOR PHENYTOIN BASED ON ONE-POINT, STEADY-STATE PLASMA-CONCENTRATION

      Therapeutic drug monitoring
    77. KNUDSEN JD; FRIMODTMOLLER N; ESPERSEN F
      EXPERIMENTAL STREPTOCOCCUS-PNEUMONIAE INFECTION IN MICE FOR STUDYING CORRELATION OF IN-VITRO AND IN-VIVO ACTIVITIES OF PENICILLIN AGAINST PNEUMOCOCCI WITH VARIOUS SUSCEPTIBILITIES TO PENICILLIN

      Antimicrobial agents and chemotherapy
    78. GILKS WR; BEST NG; TAN KKC
      ADAPTIVE REJECTION METROPOLIS SAMPLING WITHIN GIBBS SAMPLING

      Applied Statistics
    79. THURMANN PA; SONNENBURGCHATZOPOULOS C; LISSNER R
      PHARMACOKINETIC CHARACTERISTICS AND TOLERABILITY OF A NOVEL INTRAVENOUS IMMUNOGLOBULIN PREPARATION

      European Journal of Clinical Pharmacology
    80. KINOWSKI JM; RODIER M; BRESSOLLE F; FABRE D; AUGEY V; RICHARD JL; GALTIER M; GOMENI R
      BAYESIAN-ESTIMATION OF P-AMINOHIPPURATE CLEARANCE BY A LIMITED SAMPLING STRATEGY

      Journal of pharmaceutical sciences
    81. ALBALLA SR; ELSAYED YM; ALMESHAL MA; GOUDA MW
      THE EFFECTS OF CHOLESTYRAMINE AND COLESTIPOL ON THE ABSORPTION OF DICLOFENAC IN MAN

      International journal of clinical pharmacology and therapeutics
    82. HASHIMOTO Y; OZAKI J; KOUE T; ODANI A; YASUHARA M; HORI R
      SIMULATION FOR THE ANALYSIS OF DISTORTED PHARMACODYNAMIC DATA

      Pharmaceutical research
    83. ELSAYED YM; ALMESHAL MA; ALANGARY AA; ALBALLA SR; GOUDA MW
      EFFECTS OF ORAL-ADMINISTRATION OF COLESTIPOL AND CHOLESTYRAMINE ON THE PHARMACOKINETICS OF KETOPROFEN ADMINISTERED INTRAMUSCULARLY IN MAN

      International journal of pharmaceutics
    84. DURIF F; BEYSSAC E; COUDORE F; PAIRE M; ESCHALIER A; AIACHE M; LAVARENNE J
      COMPARISON BETWEEN PERCUTANEOUS AND SUBCUTANEOUS ROUTES OF ADMINISTRATION OF APOMORPHINE IN RABBIT

      Clinical neuropharmacology
    85. HUAN LC; HUA BY
      CLINICAL PHARMACOKINETIC STUDY AND SENSITIVE EFFECT OF AK-2123

      International journal of radiation oncology, biology, physics
    86. GIMMEL S; MAURER HR
      GROWTH-KINETICS OF L1210 LEUKEMIC-CELLS EXPOSED TO DIFFERENT CONCENTRATION COURSES OF METHOTREXATE IN-VITRO

      Cancer chemotherapy and pharmacology
    87. DEVALERIOLA D
      DOSE OPTIMIZATION OF ANTHRACYCLINES

      Anticancer research
    88. GOMENI R; PINEAU G; MENTRE F
      POPULATION-KINETICS AND CONDITIONAL ASSESSMENT OF THE OPTIMAL DOSAGE REGIMEN USING THE P-PHARM SOFTWARE PACKAGE

      Anticancer research
    89. VANWARMERDAM LJC; HUININK WWT; MAES RAA; BEIJNEN JH
      LIMITED-SAMPLING MODELS FOR ANTICANCER AGENTS

      Journal of cancer research and clinical oncology
    90. SIDHU JS; TRIGGS EJ; CHARLES BG; HICKEY BP
      GENTAMICIN DOSING IN ELDERLY PATIENTS BASED ON BIOELECTRICAL-IMPEDANCE ANALYSIS

      Therapeutic drug monitoring
    91. SQUASSANTE L; CAVEGGION E; BRAGGIO S; PELLEGATTI M; BAROLDI P
      A STUDY OF PLASMA DISPOSITION KINETICS OF LACIDIPINE AFTER SINGLE ORAL ASCENDING DOSES

      Journal of cardiovascular pharmacology
    92. ALMESHAL MA; ELSAYED YM; ALBALLA SR; GOUDA MW
      THE EFFECT OF COLESTIPOL AND CHOLESTYRAMINE ON IBUPROFEN BIOAVAILABILITY IN MAN

      Biopharmaceutics & drug disposition
    93. KAWAKAMI J; YAMAMOTO K; SAWADA Y; IGA T
      PREDICTION OF BRAIN DELIVERY OF OFLOXACIN, A NEW QUINOLONE, IN THE HUMAN FROM ANIMAL DATA

      Journal of pharmacokinetics and biopharmaceutics
    94. TANIGAWARA Y; YANO I; KAWAKATSU K; NISHIMURA K; YASUHARA M; HORI R
      PREDICTIVE PERFORMANCE OF THE BAYESIAN-ANALYSIS - EFFECTS OF BLOOD-SAMPLING TIME, POPULATION PARAMETERS, AND PHARMACOSTATISTICAL MODEL

      Journal of pharmacokinetics and biopharmaceutics
    95. BONACORSI SP; SCAVIZZI MR; GUIYOULE A; AMOUROUX JH; CARNIEL E
      ASSESSMENT OF A FLUOROQUINOLONE, 3 BETA-LACTAMS, 2 AMINOGLYCOSIDES, AND A CYCLINE IN TREATMENT OF MURINE YERSINIA-PESTIS INFECTION

      Antimicrobial agents and chemotherapy
    96. CHENG HY; GONG YM; JUSKO WJ
      COMPUTER-PROGRAM FOR CALCULATING DISTRIBUTION PARAMETERS FOR DRUGS BEHAVING NONLINEARLY THAT IS BASED ON DISPOSITION DECOMPOSITION ANALYSIS

      Journal of pharmaceutical sciences
    97. TSUJI A; KANEKO Y; YAMAGUCHI K; GOTO S
      CORRELATION BETWEEN THE IN-VITRO AND IN-VIVO EFFECTS OF 14 BETA-LACTAM COMPOUNDS IN MICE WITH SYSTEMIC INFECTION

      Chemotherapy
    98. AARONS L
      SPARSE DATA-ANALYSIS

      European journal of drug metabolism and pharmacokinetics
    99. RITSCHEL WA
      IDENTIFICATION OF POPULATIONS AT RISK IN DRUG-TESTING AND THERAPY - APPLICATION TO ELDERLY PATIENTS

      European journal of drug metabolism and pharmacokinetics
    100. DAVIDIAN M; GILTINAN DM
      ANALYSIS OF REPEATED MEASUREMENT DATA USING THE NONLINEAR MIXED EFFECTS MODEL

      Chemometrics and intelligent laboratory systems


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 12/12/19 alle ore 14:53:40